Neonatal drug trials: impact of EU and US paediatric regulations

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Archives of Disease in Childhood: Fetal and Neonatal Edition

• Publication date

  2014-05-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/archdischild-2013-305900PMID 24792777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The pediatric studies initiative: after 15 years have we reached the limits of the law?

  2014cited by this paper
• Federal legislation and the advancement of neonatal drug studies.

  2013cited by this paper
• Pediatric Versus Adult Drug Trials for Conditions With High Pediatric Disease Burden

  2012cited by this paper
• Stimulation programs for pediatric drug research – do children really benefit?

  2007cited by this paper

• A Quantitative Review of Un-licensed and Off-label Medicines Use in Children Aged 0-2 Years in the Private Sector in South Africa: Extent, Challenges, and Implications.

  2024cites this paper
• Development of Best Evidence Dosing Recommendations for Term and Preterm Neonates (NeoDose Project)

  2023cites this paper
• External Validation of a Vancomycin Population Pharmacokinetic Model and Developing a New Dosage Regimen in Neonates

  2022cites this paper
• Paediatric drugs trials in China

  2020cites this paper
• Postsurgery analgesic and sedative drug use in a French neonatal intensive care unit: A single-center retrospective cohort study.

  2019cites this paper
• Drug evaluation studies in neonates: how to overcome the current limitations

  2018influential citation
• Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates

  2018cites this paper
• Drug evaluation in children 10years after the European pediatric regulation current challenges and perspectives.

  2018cites this paper
• Capacities and Competences for Drug Evaluation in European Neonatal Intensive Care Units: A Survey and Key Issues for Improvement

  2018cites this paper
• Antimicrobial dosing in neonates

  2017cites this paper
• Better medicines for neonates: Improving medicine development, testing, and prescribing.

  2017cites this paper
• Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry

  2017cites this paper
• Posologie des antibiotiques chez le nouveau-né : variations des pratiques et comment y remédier ?

  2016cites this paper
• [Dosing regimens of antibiotics in neonates: Variations in clinical practice and what should be done?].

  2016cites this paper
• Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey

  2015cites this paper
• Neonatal drug therapy: The first frontier of therapeutics for children

  2015influential citation
• Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection

  2015cites this paper
• Using skin for drug delivery and diagnosis in the critically ill.

  2014cites this paper
• Off-label drug in the newborn

  2014cites this paper
• Pharmacoepidemiology and Prescription

  year unknowncites this paper